Related content

Cathepsin D and Breast Cancer

By Westley B.R.   May F.E.B.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 15-24

Elsevier

Access to resources Recommend Favorite

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

By Kute T.E.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 1, 1998-01 ,pp. : 9-16

Springer Publishing Company

Access to resources Recommend Favorite

Immunoradiometric Measurement of pS2 in Breast Cancer: Correlation with Steroid Receptors and Plasminogen Activators

By Luqmani Yunus   Temmim Labiba   Memon Anjum   Parkar Abdulhamid   Ali Majda   Motawy Mohammed   Baker Hisham  

Acta Oncologica, Vol. 38, Iss. 6, 1999-09 ,pp. : 805-814

Informa Healthcare

Access to resources Recommend Favorite

Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases

By Têtu B.  

Breast Cancer Research and Treatment, Vol. 55, Iss. 2, 1999-05 ,pp. : 135-145

Springer Publishing Company

Access to resources Recommend Favorite

A Novel Aspartic Protease Gene, ALP56, is Up-Regulated in Human Breast Cancer Independently from the Cathepsin D Gene

By Kondoh K.   Tsuji N.   Kamagata C.   Sasaki M.   Kobayashi D.   Yagihashi A.   Watanabe N.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 1, 2003-03 ,pp. : 37-44

Springer Publishing Company

Access to resources Recommend Favorite